Skip to main content
. 2017 May 18;12(5):e0177903. doi: 10.1371/journal.pone.0177903

Table 2. Clinicopathologic associations between triple-negative and ER-positive breast cancers.

Univariate Multivariate
Variable ER-Positive
(n = 149)
Triple-Negative
(n = 72)
OR (95% CI) p value OR (95% CI) p value
Age 1.00 (0.97, 1.03) 0.765
    mean±SD 52.41 ± 9.26 52 ± 10.17
    median (IQR) 52 (46, 60) 52 (45, 58.25)
Histologic Grade
    well, moderate 126 (84.56) 9 (12.5) Reference
    poor 23 (15.44) 63 (87.5) 38.35 (17.52, 92.89) <0.001 12.96 (5.20, 35.32) <0.001
Axillary Nodal Status
    negative 94 (63.09) 48 (66.67) Reference
    positive 55 (36.91) 24 (33.33) 0.85 (0.47, 1.54) 0.603
Ki67
    mean±SD 16.47 ± 17.64 64.47 ± 25.08
    median (IQR) 10 (5, 25) 70 (48.75, 80)
    <14% 104 (69.80) 5 (6.94) Reference
    ≥14% 45 (30.20) 67 (93.06) 30.97 (12.77, 92.97) <0.001 7.16 (2.30, 25.20) <0.001
Lesion Size
    mean±SD 2.36 ± 1.24 2.13 ± 0.92
    median (IQR) 2.1 (1.5, 2.7) 1.95 (1.5, 2.5)
    ≤2cm 68 (45.64) 40 (55.56) Reference
    >2cm 81 (54.36) 32 (44.44) 0.67 (0.38, 1.18) 0.168
Recurrence
    none 145 (97.32) 65 (90.28) Reference
    event 4 (2.68) 7 (9.72) 3.9 (1.14, 15.34) 0.035 2.78 (0.49, 21.95) 0.293

OR: odds ratio